Most Recent
BlueScope Steel has raised concerns over the ACCC’s subpoenas to produce documents in its civil penalty proceedings against the steel company, saying it may significantly broaden the regulator's claims about which businesses are its competitors.
The Australian arm of Fuchs Lubricants has succeeded in invalidating two patents owned by Quakers Chemicals, with the Full Federal Court finding the inventions were not novel because Quakers had tested them in public prior to applying for registration with IP Australia.
Members of the Binetter family have filed proceedings against the bankruptcy trustees for the estate of Emil Binetter, the late founder of juice company Nudie, seeking documents on settlements they have reached in cases over debts or losses claimed against the family.
A mid-trial settlement has been reached in a lawsuit brought by the liquidators of collapsed steel giant Arrium against 10 former company directors and officers for allegedly engaging in insolvent trading.
A shareholder class action against Crown Resorts can access transcripts of interviews conducted by the Victorian gaming regulator with former top brass and two Crown employees who were arrested in China in 2016 as part of a crackdown on gambling
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
Westpac has been accused by the corporate regulator of insider trading before the $16 billion privatisation of electricity provider Ausgrid.
Victoria’s attorney-general has appointed star senior counsel for the banking royal commission, Rowena Orr QC, as the state’s highest legal adviser.
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF -- including pre-implantation genetic testing -- are the targets of a new class action investigation.
The liquidators of Forge Group have won court approval to expand their insider trading case against construction company Clough over the $187 million sale of its stake in the failed engineering and construction firm.